Free Trial
→ Altucher: Turn $900 into $108,000 in just 12 months? (From Paradigm Press) (Ad)

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover
These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
4.6068 of 5 stars		$14.333.3%N/A-5.38Buy$33.71
Ultragenyx Pharmaceutical (RARE)
4.3767 of 5 stars		$27.985.8%N/A-4.76Moderate Buy$83.64
Sarepta Therapeutics (SRPT)
4.761 of 5 stars		$13.831.5%N/A-5.14Hold$52.92
Pfizer (PFE)
4.9808 of 5 stars		$25.380.9%6.78%18.40Hold$28.55
Exelixis (EXEL)
4.8318 of 5 stars		$44.971.1%N/A20.47Moderate Buy$45.33
Moderna (MRNA)
4.2672 of 5 stars		$34.776.2%N/A-3.99Hold$46.11
United Therapeutics (UTHR)
4.9847 of 5 stars		$303.131.8%N/A12.07Moderate Buy$383.08
Biogen (BIIB)
4.9324 of 5 stars		$130.111.8%N/A12.86Hold$186.37
Sanofi (SNY)
3.6482 of 5 stars		$49.681.9%3.20%17.74Buy$61.50
Eli Lilly and Company (LLY)
4.9831 of 5 stars		$789.531.7%0.76%64.24Moderate Buy$1,012.56
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

ACT FAST! Congress Is POURING Into This Stock
May 23, 2025

ACT FAST! Congress Is POURING Into This Stock

Lawmakers are making big trades again; Chris Markoch shares 3 big congressional buys, including one surprising pick that’s down over 30%.

Watch Video

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines